Diet or drugs? new study tests if fasting beats pills for fatty liver disease

NCT ID NCT06845345

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring (fibrosis) better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight or obesity and heart or metabolic risks (like type 2 diabetes or high blood pressure) will be followed for six months. The goal is to see if the diet approach is a safer or more effective way to manage fatty liver disease and prevent long-term liver damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIO METABOLIC RISK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Franciscus

    Rotterdam, 3045 PM, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.